Skip to main content
Fig. 5 | Fluids and Barriers of the CNS

Fig. 5

From: CSF hyperdynamics in rats mimicking the obesity and androgen excess characteristic of patients with idiopathic intracranial hypertension

Fig. 5

CSF androgen analysis and testosterone treatment of Zucker rats. A CSF testosterone levels in lean and obese Zucker rats, n = 3–4. B CSF androstenedione levels in lean and obese Zucker rats, n = 3–4. C CSF testosterone levels in lean and testosterone-treated obese (four weeks, obese + TT) Zucker rats, n = 3–4 (after one outlier removed from the obese + TT group). D CSF androstenedione levels in lean and obese + TT Zucker rats (after one outlier removed from the obese + TT group), n = 3–4. E Bodyweight as a function of time of lean (n = 22) and obese + TT (n = 20) Zucker rats. Error bars are within the symbols. F Bodyweight at time of experimentation, G Bodyweight gain over testosterone injection period (final four weeks before experimentation), n = 16–22. Statistical significance evaluated with Student’s unpaired t-test and results shown as mean ± SEM. *p < 0.05, ***p < 0.001, ns = not significant

Back to article page

Fluids and Barriers of the CNS

ISSN: 2045-8118